💨 Abstract
Scientists at King's College London are exploring a new form of immunotherapy for certain types of cancer, such as breast and ovarian cancers that express HER2. They are using a different antibody type, IgE, which activates the immune system in a unique way, stimulating otherwise inactive immune cells in the tumor's microenvironment.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Ecom Express enhances customer trust and communication with Truecaller's Customer Experience Solution Suite
Poland State Secy Wladyslaw Bartoszewski on Raisina Dialogue, Trump tariffs, and Starlink dispute
PEAKLIFE Regatta 2025: From fashion designer Varoin Marwah's Coastal Calm SS '25 splash show to a thrilling nautical spin on the sea, it was a magical weekend in Mumbai
Capital appreciation outpaces rental income in India's top housing markets: Anarock report
Rapid7 Announces Global Capability Center in India
Defence Minister Rajnath Singh, US Intelligence Chief Tulsi Gabbard hold talks in Delhi
Glaucoma Awareness Walk Highlights the Importance of Early Detection and Treatment
DoT announces launch of 5G Innovation Hackathon 2025
Latest2All.com: The Ultimate Hub for AI-Powered Database Management, Tools & Tutorials
Wholesale price inflation inches up to 2.38 pc in Feb
Powered by MessengerX.io